Biomedical APIs Need Contract and Provenance Controls
Holding
An API used in biomedical workflows must define not only its data schema, but also provenance, version behavior, authorization, and failure handling.
Issue
APIs are often treated as transport layers. In practice, they determine which scientific facts cross system boundaries, how they are interpreted, and whether downstream users can identify their source.
Analysis
The issue is silent contract drift: a field changes meaning, an upstream result is revised, or a service returns partial data without making the condition visible to consumers.
Resolution
The system should version contracts, validate payloads, expose source and freshness metadata, authenticate callers, log access, and distinguish unavailable, incomplete, and negative results. Breaking changes should follow a reviewed migration path.
Evidence Package
The evidence should include schemas, contract tests, version history, access logs, error semantics, incident records, and consumer impact assessments.
Conclusion
A biomedical API is part of the evidence chain and should be governed accordingly.